Verastem, Inc. (VSTM) Reports Second Quarter 2013 Financial and Corporate Results
8/13/2013 6:42:01 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today reported financial results for the second quarter ended June 30, 2013, and also commented on certain corporate accomplishments and plans.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by